Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23049679 | 1.00 | PRKCA (0.50) | PRKCATDP1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL888659 | 0.83 | ALDH1A1 (0.50) | TDP1ALDH1A1LMNAHSD17B10GAA | |
| SCHEMBL9001018 | 0.82 | PRKCA (0.70) | PRKCATDP1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL13686673 | 0.80 | PRKCA (0.52) | PRKCATDP1ALDH1A1PRKCDPOLB | |
| SCHEMBL22556025 | 0.80 | PRKCA (0.62) | PRKCAPRKCDPOLBGAANPSR1 | |
| SCHEMBL23049605 | 0.78 | PRKCA (0.46) | PRKCAPRKCDPOLBGAANPSR1 | |
| SCHEMBL23049677 | 0.78 | PRKCA (0.46) | PRKCATDP1PRKCDPOLBGAA | |
| SCHEMBL12076262 | 0.77 | PRKCA (0.48) | PRKCATDP1ALDH1A1PRKCDPOLB | |
| SCHEMBL14727834 | 0.77 | PRKCA (0.63) | PRKCATDP1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL9019756 | 0.76 | PRKCA (0.53) | PRKCATDP1ALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8741544-B2 | Salt, photoresist composition and method for producing photoresist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-06-03 | — | — | US | disclosed |
| US-20130052588-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052588-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | RER1, COL1A1, H1-0 | PRKCA 2755/4885TDP1 1809/4885ALDH1A1 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.